Obesity

Many researchers think that Wegovy and Ozempic should be taken for life, but myriad factors can force people off the drugs

The FDA recently approved semaglutide (Wegovy) for preventing serious heart conditions in some people, but questions remain about how it works

One in four Labrador retrievers carries a gene that tricks their brain into thinking they’re starving

A plethora of new weight-loss drugs are now available in the U.S., but they aren’t necessarily the same. Here’s a guide to the latest GLP-1 receptor agonists

The world has launched into an era of injectables not just to treat obesity but to manage weight. Is that all good news?

Ozempic and similar drugs are ushering in a new era of weight management and obesity treatments, and researchers are racing to understand their impact

From new uses for weight-loss drugs to the first CRISPR gene editing therapy, these were some of the most impactful health stories of the year

Recent studies evaluate risks associated with drugs such as Wegovy and Mounjaro

Insurance plans could cover blockbuster weight-loss medications such as Wegovy and Ozempic, but the benefits may not be accessible to everyone

The new social media trend “budget Ozempic” promotes laxatives and stool softeners for weight loss, but these drugs are dangerous if misused

Clinical-trial data suggest that semaglutide, sold under the name Wegovy, slashed risk of heart attacks and other cardiovascular incidents in a trial

Limited data on adults age 60 and older raise questions on whether high-priced weight-loss drugs will really help with lowering rates of chronic illness and disability